Search
Now showing items 1-2 of 2
The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population.
(
Pharmacogenomics Journal
, 2020 , Article)
The objective of this study is to estimate the prevalence of VKORC1, CYP2C9, and CYP4F2 genetic variants and their contribution to warfarin dose variability in Qataris. One hundred and fifty warfarin-treated Qatari patients ...
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
(
Elsevier
, 2013 , Article)
Summary BackgroundVKORC1 and CYP2C9 are important contributors to warfarin dose variability, but explain less variability for individuals of African descent than for those of European or Asian descent. We aimed to identify ...